Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 64

1.

Primary HIV infection: host responses and intervention strategies.

Tindall B, Cooper DA.

AIDS. 1991 Jan;5(1):1-14. No abstract available.

PMID:
1812848
2.

CD8+ T-cell immunity to HIV infection.

Piazza P, Fan Z, Rinaldo CR Jr.

Clin Lab Med. 2002 Sep;22(3):773-97. Review.

PMID:
12244597
3.

Dynamics of T cell responses in HIV infection.

Appay V, Papagno L, Spina CA, Hansasuta P, King A, Jones L, Ogg GS, Little S, McMichael AJ, Richman DD, Rowland-Jones SL.

J Immunol. 2002 Apr 1;168(7):3660-6. Erratum in: J Immunol 2002 Jul 1;169(1):607.

4.

Cytotoxic T lymphocytes and viral evolution in primary HIV-1 infection.

Price DA, O'callaghan CA, Whelan JA, Easterbrook PJ, Phillips RE.

Clin Sci (Lond). 1999 Dec;97(6):707-18. Review.

PMID:
10585898
5.

Immune reconstitution in HIV infection.

Emery S, Lane HC.

Curr Opin Immunol. 1997 Aug;9(4):568-72. Review.

PMID:
9287177
6.

Rapid restoration of CD4 T cell subsets in subjects receiving antiretroviral therapy during primary HIV-1 infection.

Kaufmann GR, Zaunders JJ, Cunningham P, Kelleher AD, Grey P, Smith D, Carr A, Cooper DA.

AIDS. 2000 Dec 1;14(17):2643-51.

PMID:
11125882
7.

Administration of zidovudine during primary HIV-1 infection may be associated with a less vigorous immune response.

Tindall B, Carr A, Goldstein D, Penny R, Cooper DA.

AIDS. 1993 Jan;7(1):127-8. No abstract available.

PMID:
8442903
8.

Potent antiretroviral therapy of primary human immunodeficiency virus type 1 (HIV-1) infection: partial normalization of T lymphocyte subsets and limited reduction of HIV-1 DNA despite clearance of plasma viremia.

Zaunders JJ, Cunningham PH, Kelleher AD, Kaufmann GR, Jaramillo AB, Wright R, Smith D, Grey P, Vizzard J, Carr A, Cooper DA.

J Infect Dis. 1999 Aug;180(2):320-9.

PMID:
10395845
9.

Lymphocyte activation in HIV-1 infection. I. Predominant proliferative defects among CD45R0+ cells of the CD4 and CD8 lineages.

Janossy G, Borthwick N, Lomnitzer R, Medina E, Squire SB, Phillips AN, Lipman M, Johnson MA, Lee C, Bofill M.

AIDS. 1993 May;7(5):613-24.

PMID:
8318170
10.

Evidence for increased T cell turnover and decreased thymic output in HIV infection.

Douek DC, Betts MR, Hill BJ, Little SJ, Lempicki R, Metcalf JA, Casazza J, Yoder C, Adelsberger JW, Stevens RA, Baseler MW, Keiser P, Richman DD, Davey RT, Koup RA.

J Immunol. 2001 Dec 1;167(11):6663-8.

11.

Preferential and persistent depletion of CCR5+ T-helper lymphocytes with nonlymphoid homing potential despite early treatment of primary HIV infection.

Krzysiek R, Rudent A, Bouchet-Delbos L, Foussat A, Boutillon C, Portier A, Ingrand D, Sereni D, Galanaud P, Grangeot-Keros L, Emilie D; ANRS O86 PRIMOFERON A Study Group.

Blood. 2001 Nov 15;98(10):3169-71.

12.
13.

Host genetic factors that control immune responses to retrovirus infections.

Miyazawa M, Tsuji-Kawahara S, Kanari Y.

Vaccine. 2008 Jun 6;26(24):2981-96. doi: 10.1016/j.vaccine.2008.01.004. Epub 2008 Jan 22. Review.

PMID:
18255203
14.

Dynamics of T cells and TCR excision circles differ after treatment of acute and chronic HIV infection.

Lewin SR, Ribeiro RM, Kaufmann GR, Smith D, Zaunders J, Law M, Solomon A, Cameron PU, Cooper D, Perelson AS.

J Immunol. 2002 Oct 15;169(8):4657-66.

15.

Why antiviral CD8 T lymphocytes fail to prevent progressive immunodeficiency in HIV-1 infection.

Agostini C, Semenzato G.

Blood. 2002 Mar 1;99(5):1876-7. No abstract available.

16.
17.

Immunological benefits of antiretroviral therapy in very early stages of asymptomatic chronic HIV-1 infection.

Plana M, García F, Gallart T, Tortajada C, Soriano A, Palou E, Maleno MJ, Barceló JJ, Vidal C, Cruceta A, Miró JM, Gatell JM.

AIDS. 2000 Sep 8;14(13):1921-33.

PMID:
10997396
18.

FOXP3 expressing CD127lo CD4+ T cells inversely correlate with CD38+ CD8+ T cell activation levels in primary HIV-1 infection.

Ndhlovu LC, Loo CP, Spotts G, Nixon DF, Hecht FM.

J Leukoc Biol. 2008 Feb;83(2):254-62. Epub 2007 Nov 2.

PMID:
17982112
19.

Activated naive and memory CD4+ and CD8+ subsets in different stages of HIV infection.

Ginaldi L, De Martinis M, D'Ostilio A, Di Gennaro A, Marini L, Profeta V, Quaglino D.

Pathobiology. 1997;65(2):91-9.

PMID:
9253033
20.

T-lymphocyte subsets in HIV-infected and high-risk HIV-uninfected adolescents: retention of naive T lymphocytes in HIV-infected adolescents. The Adolescent Medicine HIV/AIDS Research Network.

Douglas SD, Rudy B, Muenz L, Starr SE, Campbell DE, Wilson C, Holland C, Crowley-Nowick P, Vermund SH.

Arch Pediatr Adolesc Med. 2000 Apr;154(4):375-80.

PMID:
10768676

Supplemental Content

Support Center